Oramed Pharmaceuticals Inc.

Director's Dealing • May 4, 2022

SEC Form 4
------------	--

FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

OMB APPROVAL

OMB Number:	3235-0287
Estimated average burden
hours per response:	0.5

	Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).	Check this box if no longer subject to	STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
1. Name and Address of Reporting Person* Rozov Yadin (Last) (First) (Middle) 1185 AVENUE OF THE AMERICAS, THIRD FLOOR						2. Issuer Name and Ticker or Trading Symbol ORAMED PHARMACEUTICALS INC. [ ORMP ]					(Check all applicable) X Director	Officer (give title	5. Relationship of Reporting Person(s) to Issuer 10% Owner		Other (specify
						3. Date of Earliest Transaction (Month/Day/Year) 05/02/2022								below)			below)
(Street) NEW YORK		NY 10036		4. If Amendment, Date of Original Filed (Month/Day/Year)									6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person
(City)		(State)	(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1. Title of Security (Instr. 3) 2. Transaction Date					(Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. 8)		Transaction Code (Instr. 5)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and			5. Amount of Securities Beneficially Owned Following Reported		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)		7. Nature of Indirect Beneficial Ownership (Instr. 4)
								Code V		Amount		(A) or (D)	Price		Transaction(s) (Instr. 3 and 4)
Common Stock					05/02/2022	Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)		A		4,500		A	(1)		4,500		D
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)		4. 5. Number Transaction of Code (Instr. Derivative 8) Securities Acquired (A) or Disposed		6. Date Exercisable and 7. Title and Expiration Date Amount of (Month/Day/Year) Securities Underlying Derivative Security (Instr. 3 and 4)							8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

	Security						(A) or Disposed of (D) (Instr. 3, 4 and 5)				(Instr. 3 and 4)			Following Reported Transaction(s) (Instr. 4)	(I) (Instr. 4)
			Code V		(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	\$5.14	05/02/2022	A		7,500		(2)	05/02/2032 Common	Stock	7,500	\$0	7,500	D

Explanation of Responses:

1. Represents Restricted Stock Units ("RSUs") that will vest in 4 installments as follows: 1,125 shall vest on each of May 2, 2023, May 2, 2024, May 2, 2025 and May 2, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

2. The Stock Option will vest in 4 installments as follows: 1,875 shall vest on each of May 2, 2023, May 2, 2024, May 2, 2025 and May 2, 2026.

/s/ Yadin Rozov 05/03/2022

** Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.